TVTX

Travere Therapeutics (TVTX)

Travere Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:TVTX

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/15	05:05	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:TVTX	Travere Therapeutics Inc
2024/06/12	06:00	GlobeNewswire Inc.	Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:TVTX	Travere Therapeutics Inc
2024/05/16	06:00	GlobeNewswire Inc.	Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:TVTX	Travere Therapeutics Inc
2024/05/14	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TVTX	Travere Therapeutics Inc
2024/05/11	05:06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TVTX	Travere Therapeutics Inc
2024/05/11	05:06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TVTX	Travere Therapeutics Inc
2024/05/11	05:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TVTX	Travere Therapeutics Inc
2024/05/11	05:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TVTX	Travere Therapeutics Inc
2024/05/11	05:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TVTX	Travere Therapeutics Inc
2024/05/11	05:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TVTX	Travere Therapeutics Inc
2024/05/10	05:30	GlobeNewswire Inc.	Travere Therapeutics to Present at National Kidney Foundation Spring Clinical Meetings and the 61st European Renal Association Congress	NASDAQ:TVTX	Travere Therapeutics Inc
2024/05/09	05:30	GlobeNewswire Inc.	Travere Therapeutics to Present at Upcoming Investor Conferences	NASDAQ:TVTX	Travere Therapeutics Inc
2024/05/07	05:46	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:TVTX	Travere Therapeutics Inc
2024/05/07	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TVTX	Travere Therapeutics Inc
2024/05/07	05:01	GlobeNewswire Inc.	Travere Therapeutics Reports First Quarter 2024 Financial Results	NASDAQ:TVTX	Travere Therapeutics Inc
2024/04/30	05:30	GlobeNewswire Inc.	Travere Therapeutics to Report First Quarter 2024 Financial Results	NASDAQ:TVTX	Travere Therapeutics Inc
2024/04/24	20:05	GlobeNewswire Inc.	Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for the treatment of IgA Nephropathy	NASDAQ:TVTX	Travere Therapeutics Inc
2024/04/24	16:00	PR Newswire (Canada)	CSL Vifor and Travere Therapeutics Announce European Commission approves FILSPARI® (sparsentan) for the treatment of IgA Nephropathy	NASDAQ:TVTX	Travere Therapeutics Inc
2024/04/24	16:00	PR Newswire (US)	CSL Vifor and Travere Therapeutics Announce European Commission approves FILSPARI® (sparsentan) for the treatment of IgA Nephropathy	NASDAQ:TVTX	Travere Therapeutics Inc
2024/04/05	05:30	GlobeNewswire Inc.	Travere Therapeutics to Present Abstracts at the Society for Inherited Metabolic Disorders and Genetic Metabolic Dieticians International	NASDAQ:TVTX	Travere Therapeutics Inc
2024/04/04	05:30	GlobeNewswire Inc.	Travere Therapeutics to Present Abstracts on FILSPARI® (sparsentan) in IgA Nephropathy at World Congress of Nephrology and the American Nephrology Nurses Association	NASDAQ:TVTX	Travere Therapeutics Inc
2024/03/14	06:00	GlobeNewswire Inc.	Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:TVTX	Travere Therapeutics Inc
2024/03/11	20:05	GlobeNewswire Inc.	Travere Therapeutics Submits Supplemental New Drug Application to the U.S. Food and Drug Administration Seeking Full Approval of FILSPARI® (sparsentan) for the Treatment of IgA Nephropathy (IgAN)	NASDAQ:TVTX	Travere Therapeutics Inc
2024/02/27	06:30	GlobeNewswire Inc.	Travere Therapeutics to Present at Upcoming Investor Conferences	NASDAQ:TVTX	Travere Therapeutics Inc
2024/02/24	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TVTX	Travere Therapeutics Inc
2024/02/23	21:05	GlobeNewswire Inc.	Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatment of IgA Nephropathy	NASDAQ:TVTX	Travere Therapeutics Inc
2024/02/23	16:00	PR Newswire (Canada)	CSL Vifor and Travere Therapeutics announce sparsentan receives positive CHMP opinion for the treatment of IgA nephropathy	NASDAQ:TVTX	Travere Therapeutics Inc
2024/02/23	16:00	PR Newswire (US)	CSL Vifor and Travere Therapeutics announce sparsentan receives positive CHMP opinion for the treatment of IgA nephropathy	NASDAQ:TVTX	Travere Therapeutics Inc
2024/02/20	22:10	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:TVTX	Travere Therapeutics Inc
2024/02/16	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TVTX	Travere Therapeutics Inc